TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01532804

2nd-line Treatment of Metastatic Colorectal Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“too slow recruiting”

The sponsor’s own words in the registry.

Life of this trial

2011201220132014201520162017201820192020Started2011-07-28Registered2012-02-10Primary completion2016-05-12Stopped2019-01

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Sponsor type
University, hospital or other
Conditions
Metastatic Colorectal Cancer
Interventions
bevacizumab, oxaliplatin and 5FU combination; Bevacizumab, oxaliplatin and raltitrexed combination
Participants
83
Sites
1
Countries
France

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.